Literature DB >> 18815587

Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo.

Joseph A Roche1, Richard M Lovering, Robert J Bloch.   

Abstract

The protein, dysferlin, mediates sarcolemmal repair in vitro, implicating defective membrane repair in dysferlinopathies. To study the role of dysferlin in vivo, we assessed contractile function, sarcolemmal integrity, and myogenesis before and after injury from large-strain lengthening contractions in dysferlin-null and control mice. We report that dysferlin-null muscles produce higher contractile torque, and are equally susceptible to initial injury but recover from injury more slowly. Two weeks after injury, control muscles retain fluorescein dextran and do not show myogenesis. Dysferlin-null muscles do not retain fluorescein dextran, and show necrosis followed by myogenesis. Our data indicate that recovery of control muscles from injury primarily involves sarcolemmal repair whereas recovery of dysferlin-null muscles primarily involves myogenesis without repair and long-term survival of myofibers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815587      PMCID: PMC2662728          DOI: 10.1097/WNR.0b013e328311ca35

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  21 in total

1.  Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury.

Authors:  Richard M Lovering; Patrick G De Deyne
Journal:  Am J Physiol Cell Physiol       Date:  2003-10-01       Impact factor: 4.249

Review 2.  Mechanical injury and repair of cells.

Authors:  Katsuya Miyake; Paul L McNeil
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

3.  Quantitative assessment of degenerative changes in soleus muscle after hindlimb suspension and recovery.

Authors:  A X Bigard; D Merino; F Lienhard; B Serrurier; C Y Guezennec
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1997

4.  Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension.

Authors:  B A St Pierre; J G Tidball
Journal:  J Appl Physiol (1985)       Date:  1994-07

5.  Defective membrane repair in dysferlin-deficient muscular dystrophy.

Authors:  Dimple Bansal; Katsuya Miyake; Steven S Vogel; Séverine Groh; Chien-Chang Chen; Roger Williamson; Paul L McNeil; Kevin P Campbell
Journal:  Nature       Date:  2003-05-08       Impact factor: 49.962

6.  Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

Authors:  Mengfatt Ho; Cristina M Post; Leah R Donahue; Hart G W Lidov; Roderick T Bronson; Holly Goolsby; Simon C Watkins; Gregory A Cox; Robert H Brown
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

7.  Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse.

Authors:  Alexandre Briguet; Isabelle Courdier-Fruh; Mark Foster; Thomas Meier; Josef P Magyar
Journal:  Neuromuscul Disord       Date:  2004-10       Impact factor: 4.296

8.  Dihydropyridine and ryanodine receptor binding after eccentric contractions in mouse skeletal muscle.

Authors:  Christopher P Ingalls; Gordon L Warren; Jia-Zheng Zhang; Susan L Hamilton; R B Armstrong
Journal:  J Appl Physiol (1985)       Date:  2003-12-12

9.  Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.

Authors:  Miranda D Grounds; Jo Torrisi
Journal:  FASEB J       Date:  2004-04       Impact factor: 5.191

10.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.

Authors:  J Liu; M Aoki; I Illa; C Wu; M Fardeau; C Angelini; C Serrano; J A Urtizberea; F Hentati; M B Hamida; S Bohlega; E J Culper; A A Amato; K Bossie; J Oeltjen; K Bejaoui; D McKenna-Yasek; B A Hosler; E Schurr; K Arahata; P J de Jong; R H Brown
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

View more
  37 in total

1.  Physiological and histological changes in skeletal muscle following in vivo gene transfer by electroporation.

Authors:  Joseph A Roche; Diana L Ford-Speelman; Lisa W Ru; Allison L Densmore; Renuka Roche; Patrick W Reed; Robert J Bloch
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

Review 2.  Membrane Repair: Mechanisms and Pathophysiology.

Authors:  Sandra T Cooper; Paul L McNeil
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

3.  The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.

Authors:  Diana L Ford-Speelman; Joseph A Roche; Amber L Bowman; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

Review 4.  Ferlin proteins in myoblast fusion and muscle growth.

Authors:  Avery D Posey; Alexis Demonbreun; Elizabeth M McNally
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

5.  An in vivo rodent model of contraction-induced injury and non-invasive monitoring of recovery.

Authors:  Richard M Lovering; Joseph A Roche; Mariah H Goodall; Brett B Clark; Alan McMillan
Journal:  J Vis Exp       Date:  2011-05-11       Impact factor: 1.355

6.  Physiology, structure, and susceptibility to injury of skeletal muscle in mice lacking keratin 19-based and desmin-based intermediate filaments.

Authors:  Richard M Lovering; Andrea O'Neill; Joaquin M Muriel; Benjamin L Prosser; John Strong; Robert J Bloch
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-05       Impact factor: 4.249

7.  Coupling of excitation to Ca2+ release is modulated by dysferlin.

Authors:  Valeriy Lukyanenko; Joaquin M Muriel; Robert J Bloch
Journal:  J Physiol       Date:  2017-06-26       Impact factor: 5.182

Review 8.  X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates [Ca²⁺]i.

Authors:  Benjamin L Prosser; Ramzi J Khairallah; Andrew P Ziman; Christopher W Ward; W J Lederer
Journal:  J Mol Cell Cardiol       Date:  2012-12-06       Impact factor: 5.000

9.  Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.

Authors:  Douglas P Millay; Marjorie Maillet; Joseph A Roche; Michelle A Sargent; Elizabeth M McNally; Robert J Bloch; Jeffery D Molkentin
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

10.  Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries.

Authors:  Joseph A Roche; Richard M Lovering; Renuka Roche; Lisa W Ru; Patrick W Reed; Robert J Bloch
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-18       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.